Freedom Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,198
| Closed | -$200K | – | 831 |
|
|
2022
Q1 | $200K | Buy |
+6,198
| New | +$200K | 0.02% | 729 |
|
|
2021
Q3 | – | Sell |
-7,230
| Closed | -$223K | – | 899 |
|
|
2021
Q2 | $223K | Sell |
7,230
-497
| -6% | -$15.3K | 0.02% | 792 |
|
|
2021
Q1 | $202K | Buy |
+7,727
| New | +$202K | 0.02% | 789 |
|
|
2019
Q2 | – | Sell |
-10,735
| Closed | -$376K | – | 731 |
|
|
2019
Q1 | $376K | Buy |
+10,735
| New | +$376K | 0.03% | 453 |
|
|
2018
Q4 | – | Sell |
-6,266
| Closed | -$275K | – | 886 |
|
|
2018
Q3 | $275K | Sell |
6,266
-8,597
| -58% | -$377K | 0.02% | 737 |
|
|
2018
Q2 | $890K | Buy |
14,863
+9,412
| +173% | +$564K | 0.05% | 367 |
|
|
2018
Q1 | $250K | Buy |
+5,451
| New | +$250K | 0.01% | 942 |
|
|
2017
Q3 | – | Sell |
-8,607
| Closed | -$371K | – | 1147 |
|
|
2017
Q2 | $371K | Buy |
+8,607
| New | +$371K | 0.02% | 689 |
|